Ectopic adiposity is associated with autonomic risk factors and subclinical cardiovascular disease in young adults

Obesity
Jane J LeeMolly B Conroy

Abstract

To examine the relationship between ectopic adiposity and markers of cardiometabolic risk, autonomic control, and subclinical cardiovascular disease (CVD). Cross-sectional analyses were performed in 324 subjects with overweight and obesity. Single-slice CT images were analyzed to calculate thigh muscle attenuation (MA), a measure of ectopic adiposity. Autonomic control was assessed using low-frequency to respiratory-frequency heart rate variability (LFa/RFa ratio). Carotid intima-media thickness (IMT) was a marker of subclinical CVD. Among overweight participants, those with low MA had lower HDL-c, higher LFa/RFa ratio, and subcutaneous thigh fat compared to high MA individuals despite no difference in visceral fat or insulin resistance. Significant associations were not observed in the class I obese group. In the class II obese group, those with high MA had higher triglycerides and insulin levels, yet there was no difference in visceral fat compared to the low MA group. Mean IMT was significantly higher in the low MA compared to the high MA overweight group (0.63 mm vs. 0.58 mm, P = 0.04) but was similar between the low and high MA class II obese groups. Excess ectopic adiposity in muscle tissue is associated with metabolic an...Continue Reading

References

Jun 1, 1989·Annals of Internal Medicine·A N PeirisA H Kissebah
Aug 1, 1994·Journal of Clinical Epidemiology·M L BotsD E Grobbee
Jun 1, 1994·Circulation·U ScherrerP Nicod
Dec 24, 1997·Psychophysiology·G G BerntsonM W van der Molen
Oct 29, 1998·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·R E De MeersmanJ A Downey
Oct 8, 1999·The New England Journal of Medicine·E E CalleC W Heath
Mar 25, 2000·The American Journal of Clinical Nutrition·B H GoodpasterD E Kelley
Apr 25, 2000·Metabolism: Clinical and Experimental·B H GoodpasterD E Kelley
Jun 11, 2002·Annual Review of Nutrition·David E KelleyLen Storlien
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Antony D KarelisEric T Poehlman
Oct 20, 2007·Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society·Benhur Aysin, Elif Aysin
Jan 29, 2008·Current Diabetes Reviews·Osama HamdyEbaa Al-Ozairi
Aug 13, 2008·Archives of Internal Medicine·Norbert StefanHans-Ulrich Häring
Jun 6, 2009·European Journal of Clinical Investigation·J SztajzelE Bobbioni-Harsch
Oct 7, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S-K KimY-W Cho
Aug 12, 2010·Metabolic Syndrome and Related Disorders·M-C DubéS J Weisnagel
Oct 27, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·V PrimeauR Rabasa-Lhoret

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00366990

Software Mentioned

- Matic
- O
Slice
SAVE
SAS
AMS system
ANSAR

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.